To help keep our community authentic, we're showing information about accounts on Linktree.
ANZSA has been a member of Linktree for 4 years and joined in February 2022. The social media accounts linked to from ANZSA are: • Facebook • Email • X Besides social media accounts, ANZSA has populated their site with: • Fifty, fabulous and fundraising – The Walk50beforefifty • 'Super fit' Kaela thought she had a torn muscle. It was the first sign of the fight of her life • Read Tessa's Sarcoma Story • MLL: Molecular sequencing and sarcoma | 2025 | VCCC Alliance • Sarah Cheung's article in the NZ Herald: What is sarcoma? Auckland woman diagnosed with rare cancer on why more research is needed • A deep dive on liposarcoma | 2025 | VCCC Alliance • Applying Radiomics to Predict Outcomes in Patients with High-Grade Retroperitoneal Sarcoma Treated with Preoperative Radiotherapy • Register • The Great Sarcoma Plank-A-Thon 2026 • Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working Group - PubMed • Run for Research • Efficacy and feasibility of treating adults with paediatric chemotherapy protocols in Ewing sarcoma, rhabdomyosarcoma and osteosarcoma – A systematic review by the Australia and New Zealand Sarcoma Association clinical practice guidelines working party • Contact us to be a sarcoma spokesperson! • Donate • The Great Sarcoma Plankathon 2026 • The Fight That Couldn’t Be Trained For • A Perfect Life Shattered by Cancer • What Instinct Told Her • Everyone that gets diagnosed needs a hope story • My intuition saved my life • CREST Health Economics Symposium 2026 • Donate - GivingTuesday • Tessa's Interview on Weekend Today • Dean's Story • Listen to Dr Liz Conolly interview • The value of a second expert opinion in histopathological diagnosis of bone and soft tissue sarcoma: a systematic review - Pathology • Register: 2026 ASM • Episode 104: Soft Tissue Sarcoma Part 1 | Avoiding The Whoops Lesion - This Medical Life Podcast • Episode 105: Soft Tissue Sarcoma Part 2 | Adjuvant Therapies - This Medical Life - Omny.fm • Donate to ANZSA • 2026 ASM Program • ANZSA Newsletter - December 2024Decemeber 2024 • Listen to Prof Jeremy Lewin interview • Pioneering treatment for the rarest of cancers gives hope for terminal patients | 60 Minutes Aus • ANZSA Newsletter - August 2026 • Buy ROCK FOR A CAUSE WITH SONIC ASSAULT tickets, VIC 2025 | Moshtix • World Cancer Day – Honouring Tim Likos • International Women and Girls in Science Day 2026 • Welcoming Robert Preece to the Consumer Advisory Panel • Live Life to the Fullest, Act with Purpose • 2025 ANZSA Marathon Fundraising Events • Chondrosarcoma research publication • Rare but Real: A Dad’s Courageous Journey • Watch sarcoma awareness mission - Australian Health Journal • EPISODE 21: Rare and Diverse: Supporting Sarcoma Nursing Across Australia and New Zealand • RarebutReal2025 Fundraising Page • Cambridge mum’s gut instinct leads to rare cancer diagnosis and lifesaving surgery - NZ Herald • Register for the 2025 ANZSA Annual Scientific Meeting • Liposarcoma diagnosis: How Matthew Cameron-Glaze discovered the lump on his leg was an aggressive cancer - NZ Herald • A deep dive on liposarcoma webinar Recording • Tallangatta trek supporting sarcoma awareness set for second edition | The Border Mail | Wodonga, VIC • Donate to Olive's steps to fight sarcoma 2025 • ANZSA Merch • A systematic review on the impact of delayed local therapy in patients with Ewing sarcoma of the pelvis | Journal of Cancer Research and Clinical Oncology • Join the Olive's Steps to Fight Sarcoma Facebook Group • Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial • Become an ANZSA member • Fundraise for Us • Sarcoma Guidelines Introduction • Sarcoma Guidelines - Plain Language Summary • SARC032 Clinical Trial Findings • A survey of the prevalence of menopausal symptoms across • High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party • A systematic review of the role of chemotherapy in retroperitoneal sarcoma by the Australia and New Zealand sarcoma association clinical practice guidelines working party • Artificial Intelligence increasing accuracy at grading aggressiveness of some sarcomas • Australians battling rare cancers to be able to save tens of thousands with new drug | 7NEWS • Interview with Ged Kearney MP - Australia and New Zealand Sarcoma Association • New Research into Identifying Genes that Cause Sarcoma • Surgery at specialised sarcoma centres improves patient outcomes • What is Sarcoma? • Our Sarcoma Research • Patient and Carer Sarcoma Information • Sarcoma Fact Sheet • Life After Treatment • Publications